News
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
Telomir Pharmaceuticals to feature on Health Uncensored with Dr. Drew on Fox Business Network, discussing Telomir-1 and longevity science -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
Telomir Pharmaceuticals, Inc. appoints Dr. Itzchak Angel as Chief Scientific Advisor to lead developments in longevity science and advance Telomir-1 small molecule for age-related conditions in humans and animals -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
Telomir-1, a small molecule by Telomir Pharmaceuticals, shows promising results in promoting life quality and longevity in senior dogs. The pre-clinical-stage company's research aims to lead developments in longevity science through the treatment of age-related conditions
